EmbryoNet-AI vs Moleculent
EmbryoNet-AI vs Moleculent, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EmbryoNet-AI is on 38/100 and Moleculent on 61/100.
Where each one leads
EmbryoNet-AI
Leads on none of the measures we hold for both companies.
Moleculent
- our overall score: 61/100 against 38/100
- agent readiness: 47/100 against 21/100
- domain rating: 36/100 against 26/100
- funding raised: $46.0M against $150K
At a glance
| Measure | EmbryoNet-AI | Moleculent |
|---|---|---|
| What it is | AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids. | Mapping cell-cell communication at scale in human tissue. |
| Category | Biotech, Drug Discovery, AI, Medical Imaging | Biotech, Life Sciences, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2025 | 2019 |
| Headquarters | Lisbon, Portugal | Stockholm, Sweden |
| Status | Active | Active |
Size, funding and growth
| Measure | EmbryoNet-AI | Moleculent |
|---|---|---|
| Employees | Not published | 64 |
| Total funding | $150K | $46.0M |
| Latest round | Grant | Series B |
| LinkedIn followers | Not published | 345 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EmbryoNet-AI | Moleculent |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 38/100 | 61/100 |
| Traction | 26/100 | 56/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 8/100 | 37/100 |
| Quality | 48/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 26/100 | 36/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EmbryoNet-AI | Moleculent |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Tailwind CSS |
| Analytics | Not detected | Google Tag Manager |
| Support stack | Not detected | HubSpot |
EmbryoNet-AI vs Moleculent: common questions
Which is better, EmbryoNet-AI or Moleculent?
On our 0-100 score Moleculent rates higher (61/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EmbryoNet-AI and Moleculent compare on the numbers?
Moleculent leads on our overall score (61/100 against 38/100), agent readiness (47/100 against 21/100), domain rating (36/100 against 26/100), funding raised ($46.0M against $150K).
Read the full EmbryoNet-AI review and pricing or the Moleculent review and pricing. You can also browse other EmbryoNet-AI alternatives we track.